Principal Investigator / Group Leader – Pediatric Hematologic Malignancies Research Program
La experiencia que se espera de los solicitantes, así como las habilidades y cualificaciones adicionales necesarias para este trabajo, se enumeran a continuación.
The Josep Carreras Leukemia Research Institute (IJC) invites applications for three Principal Investigator / Group Leader positions to establish independent research groups within the newly created Pediatric Hematologic Malignancies Research Program, a joint initiative between IJC and the Institut de Recerca Sant Joan de Déu (IRSJD) at the IJC‑Sant Joan de Déu Campus in Barcelona.
Successful candidates will join a dynamic and collaborative research environment with strong links to leading pediatric oncology clinicians and access to unique patient cohorts and research infrastructures.
Research Description
Researchers recruited through this call will play a key role in shaping the scientific vision of the program, contributing to the development of an excellent research hub dedicated to improving outcomes for children with hematologic malignancies. The initiative aims to establish a world‑class multidisciplinary research program dedicated to advancing the biological understanding, diagnosis, and treatment of pediatric hematologic malignancies.
Blood cancer biology covering etiology, cell‑of‑origin, pathophysiology and resistance.
Hematopoiesis and bone marrow niche in health and disease.
Immunology and immunotherapy.
Innovative therapeutics for pediatric blood cancers.
AI‑integrated research to advance patient stratification and predict resistance.
Requirements
A PhD in Medicine, Molecular Biology, Biochemistry, Genetics, Biomedical Sciences, or a related discipline.
A strong track record of publications in leading peer‑reviewed journals.
Evidence of scientific independence, including competitive research funding.
Experience in leading and mentoring research teams.
International exposure to competitive research environments.
Experience in clinical management and/or innovation, technology transfer, and intellectual property will be considered an advantage.
Benefits
A Group Leader position for 5 years, subject to yearly evaluations. The GL can transition to a tenure position by following a formal scientific evaluation by the end of this period, subject to availability of a permanent position.
A competitive start‑up package, including personnel funding and dedicated laboratory space for a research team of 4–6 members.
Access to state‑of‑the‑art core facilities at IJC and SJD campuses, including single‑cell OMICs, proteomics, multi‑dimensional flow cytometry and cell sorting, animal facility, cell & molecular laboratories, microscopy, clinical research & GMP cell therapy units.
Integration into a highly collaborative research environment.
Direct interaction with clinical programs in pediatric oncology, enabling strong translational research.
The research program is in Barcelona, within Catalonia’s BioRegion, one of Europe’s leading biomedical innovation ecosystems and a major hub for oncology clinical research.
Deadline
Please submit your application by May 31st, 2026.
How to Apply
Send your application documents through the IJC HR platform. Please include:
Curriculum vitae – maximum 4 pages, including list of publications and funding history.
Research statement – maximum 3 pages describing past achievements and a forward‑looking research vision for the Program.
Strategic vision statement – maximum 1 page on internationalisation, leadership, and team management.
Cover letter – maximum 1 page explaining the applicant’s interest in the Program and alignment with its goals.
Contact details of three referees – letters of reference are not requested at this stage;
referees will be contacted only for shortlisted candidates.
Equal Opportunity
The IJC is an equal‑opportunity employer. xhfqzwm We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, or other legally protected characteristics.
#J-18808-Ljbffr